Fenway Health | The Fenway Institute

Research site

(Unclaimed)

Location

1340 Boylston Street, Boston, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

Emtricitabine

Lenacapavir

Truvada

fluorouracil

PrEP

MK-8527-007

imiquimod

Tenofovir

TDF

MK-8527

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 37 total trials

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

The purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine...

Active, not recruiting

Genital Herpes

Biological: BEXSERO

Biological: mRNA-1608

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

This double-blind, placebo-controlled study is designed to assess the safety, tolerability, and pharmacokinetics of oral MK-8527 taken once monthly (...

Active, not recruiting

HIV

HIV Pre-exposure Prophylaxis

Drug: MK-8527

Drug: Placebo to MK-8527

SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

This is a single-arm, observational study of HIV-negative MSM with substance use disorder. Those who meet pre-screening criteria will attend a Screen...

Enrolling

Substance Use

Adherence, Treatment

Drug: Descovy or Truvada

Device: Beiwe

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3)

The goal of this clinical study is to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofov...

Enrolling

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Tablet

Drug: Lenacapavir Injection